Snapshot

The Accelerated Registration of Drugs pathway has been developed by the Ministry of Health of the Russian Federation of Russia.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from Canada EU-EMA United States

20 working days (instead of 160 working days).